1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the quarter ended March 31, 2025, no director or executive officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: The following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended June 30, 2025.
+Added: No trading arrangements were terminated by our directors and executive officers during the quarter ended June 30, 2025.
+Added: Trading Arrangement
+Added: Name and Position Action Date Rule 10b5-1* Non-Rule
+Added: 10b5-1** Total Number of
+Added: Shares to be Sold Expiration
+Added: Abraham Ceesay
+Added: Adopt 6/3/2025 x 2,354 9/4/2025
+Added: Chief Financial Officer
+Added: Adopt 6/9/2025 x To Be Determined (1)
+Added: Principal Accounting Officer
+Added: Adopt 6/13/2025 x To Be Determined (1) (2)
+Added: * Intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: ** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: (1) The aggregate number of shares to be sold pursuant to the trading arrangements listed above are dependent on the amount of tax withholding required upon the vesting of restricted stock units, and, therefore, is indeterminable at this time.
+Added: (2) Includes shares to be sold which are scheduled to be purchased through the Company’s employee stock purchase plan on December 31, 2025.
Pacira BioSciences, Inc.
2 unchanged sentences
Exhibit Number Description
−Removed: Third Amended and Restated Bylaws.
Settlement Agreement, dated April 7, 2025, by and between Pacira BioSciences, Inc.
2 unchanged sentences
(f/k/a Jiangsu Hengrui Medicine Co., Ltd.).(1) †† ##
−Removed: Amended and Restated 2014 Inducement Plan.
−Removed: Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan.
−Removed: Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan.
+Added: Amended and Restated 2011 Stock Incentive Plan.(2)***
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a), as amended.*
3 unchanged sentences
101 The following materials from the Quarterly Report on Form 10-Q of Pacira BioSciences, Inc.
−Removed: for the quarter ended March 31, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language):
+Added: for the quarter ended June 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets;
(ii) the Condensed Consolidated Statements of Operations;
−Removed: (iii) the Condensed Consolidated Statements of Comprehensive Income;
+Added: (iii) the Condensed Consolidated Statements of Comprehensive (Loss) Income;
(iv) the Condensed Consolidated Statements of Stockholders’ Equity;
7 unchanged sentences
The omitted information (i) is not material and (ii) is the type that the Registrant treats as private or confidential.
−Removed: ## Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
−Removed: The Company hereby undertakes to supplementally furnish copies of any omitted schedules and exhibits to the Securities and Exchange Commission upon request.
−Removed: (1) Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K, filed on March 14, 2025.
−Removed: (2) Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
−Removed: (3) Incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
−Removed: (4) Incorporated by reference to Exhibit 10.3 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.
+Added: (1) Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q, filed on May 8, 2025.
+Added: (2) Incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed on June 13, 2025.
Pacira BioSciences, Inc.
2 unchanged sentences
PACIRA BIOSCIENCES, INC.
−Removed: May 8, 2025 By:
+Added: August 5, 2025 By:
Chief Executive Officer and Director
(Principal Executive Officer)
−Removed: May 8, 2025 By:
+Added: August 5, 2025 By:
Chief Financial Officer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.